Accelerated Pharma (Accelerated Pharma) Beginning Cash Position : $0.06 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Beginning Cash Position?

Accelerated Pharma's Beginning Cash Position for the quarter that ended in Mar. 2017 was $0.06 Mil.

Accelerated Pharma's quarterly Beginning Cash Position increased from Sep. 2016 ($0.01 Mil) to Dec. 2016 ($0.13 Mil) but then declined from Dec. 2016 ($0.13 Mil) to Mar. 2017 ($0.06 Mil).

Accelerated Pharma's annual Beginning Cash Position increased from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($0.42 Mil) and increased from Dec. 2015 ($0.42 Mil) to Dec. 2016 ($0.67 Mil).

Accelerated Pharma Beginning Cash Position Historical Data

The historical data trend for Accelerated Pharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Beginning Cash Position Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Beginning Cash Position

0.42

0.67

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Beginning Cash Position	Get a 7-Day Free Trial			0.66	0.23	0.01	0.13	0.06

Accelerated Pharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Accelerated Pharma Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines